First Test of FragMAX Platform Delivers for HZB Compound Libraries
image: User interface for FragMAX screening platform at MAX IV Researchers at Helmholtz-Zentrum Berlin (HZB), in collaboration with MAX IV’s BioMAX team, have validated a new diverse universal compound library used in the process of drug discovery and development. The HZB study, published in CellPress, sourced the power of MAX IV’s macromolecular crystallography beamline BioMAX